BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 10559280)

  • 1. Integration of hepadnavirus DNA in infected liver: evidence for a linear precursor.
    Yang W; Summers J
    J Virol; 1999 Dec; 73(12):9710-7. PubMed ID: 10559280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection of ducklings with virus particles containing linear double-stranded duck hepatitis B virus DNA: illegitimate replication and reversion.
    Yang W; Summers J
    J Virol; 1998 Nov; 72(11):8710-7. PubMed ID: 9765413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competition in vivo between a cytopathic variant and a wild-type duck hepatitis B virus.
    Lenhoff RJ; Luscombe CA; Summers J
    Virology; 1998 Nov; 251(1):85-95. PubMed ID: 9813205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection.
    Le Mire MF; Miller DS; Foster WK; Burrell CJ; Jilbert AR
    J Virol; 2005 Oct; 79(19):12242-52. PubMed ID: 16160150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of spontaneous mutations in an avian hepadnavirus infection.
    Pult I; Abbott N; Zhang YY; Summers J
    J Virol; 2001 Oct; 75(20):9623-32. PubMed ID: 11559794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression and active virus replication in the liver after injection of duck hepatitis B virus DNA into the peripheral vein of ducklings.
    Tagawa M; Yokosuka O; Imazeki F; Ohto M; Omata M
    J Hepatol; 1996 Mar; 24(3):328-34. PubMed ID: 8778201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Establishment of an in vivo model for duck hepatitis B virus infection using Hubei duckling].
    Hu Q; Fang Y; Zhang ZM; Zhang XY; Zhang ZH; Yang DL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):113-5. PubMed ID: 18574531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative competitive PCR assay for the covalently closed circular form of the duck hepatitis B virus.
    Addison WR; Wong WW; Fischer KP; Tyrrell DL
    Antiviral Res; 2000 Oct; 48(1):27-37. PubMed ID: 11080538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver.
    Zhang YY; Zhang BH; Theele D; Litwin S; Toll E; Summers J
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12372-7. PubMed ID: 14528003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute liver injury following infection with a cytopathic strain of duck hepatitis B virus.
    Lenhoff RJ; Luscombe CA; Summers J
    Hepatology; 1999 Feb; 29(2):563-71. PubMed ID: 9918936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nucleoside analogue therapy on duck hepatitis B viral replication in hepatocytes and bile duct epithelial cells in vivo.
    Nicoll A; Locarnini S; Chou ST; Smallwood R; Angus P
    J Gastroenterol Hepatol; 2000 Mar; 15(3):304-10. PubMed ID: 10764033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dynamic state of viral competition in a chronic avian hepadnavirus infection.
    Zhang YY; Summers J
    J Virol; 2000 Jun; 74(11):5257-65. PubMed ID: 10799602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of age- and dose-related outcomes of duck hepatitis B virus infection.
    Jilbert AR; Botten JA; Miller DS; Bertram EM; Hall PM; Kotlarski J; Burrell CJ
    Virology; 1998 May; 244(2):273-82. PubMed ID: 9601498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-hepatitis B virus activity of α-DDB-FNCG, a novel nucleoside-biphenyldicarboxylate compound in vitro and in vivo.
    Yang Q; Zhao X; Yu W; He W; Fang X; Zang L; Wan N; Wang Q; Zheng L; Chang J
    J Pharmacol Sci; 2014; 126(3):208-15. PubMed ID: 25409748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral effects of PNA in duck hepatitis B virus infection model.
    Chen ZY; Cheng AC; Wang MS; Xu DW; Zeng W; Li Z
    Acta Pharmacol Sin; 2007 Oct; 28(10):1652-8. PubMed ID: 17883953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis.
    Reaiche GY; Le Mire MF; Mason WS; Jilbert AR
    Virology; 2010 Oct; 406(2):286-92. PubMed ID: 20705309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocytes traffic and export hepatitis B virus basolaterally by polarity-dependent mechanisms.
    Bhat P; Snooks MJ; Anderson DA
    J Virol; 2011 Dec; 85(23):12474-81. PubMed ID: 21937643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Establishment of a method to detect duck hepatitis B virus covalently closed circular DNA based on rolling circle amplification].
    Su HL; Wang HM; Ran JY; Wang Z; Li HY; Yang Y; Xu DP; Liu YM
    Bing Du Xue Bao; 2014 Jul; 30(4):382-6. PubMed ID: 25272590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks.
    Jilbert AR; Miller DS; Scougall CA; Turnbull H; Burrell CJ
    Virology; 1996 Dec; 226(2):338-45. PubMed ID: 8955053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection.
    Miller DS; Halpern M; Kotlarski I; Jilbert AR
    Virology; 2006 May; 348(2):297-308. PubMed ID: 16469347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.